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horses. The composition appears to function as a biolog

ical inhibitor and has antibacterial and antifungal activ
ity when applied to the normal ?ora and secretions of
the epidermis and mucous membranes. Also, the com

position has antipruritic and anti-in?ammatory activity.
The composition is efficacious in the treatment of le

sions produced by bacteria, fungi, allergies, viruses,
trauma, and burns to the epidermis, dermis, muscles and
mucous membranes of the surface or in body cavities of
animals and man.

The composition preferably comprises an aqueous solu
tion of dextrose, citric acid and a buffering mixture of
the salts of citric acid and acetic acid to provide an

optional pH between 3.0 to 6.5 for various wound le
510115.

21 Claims, No Drawings
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mal and muscular burns and wounds, which composi
COMPOSITION FOR TOPICAL AND INFUSION
TREATMENT OF WOUNDS AND BURNS
CROSS REFERENCE TO RELATED
APPLICATIONS

tion comprises an aqueous solution of dextrose or dex

trose metabolite, a buffering mixture of weak organic
acids and alkali metal salts of weak organic acids, and a
5 carrier, the composition being characterized as a vis
cous solution having a pH varying from 3.0 to 6.5 de—

This application is a continuation in part of Ser. No.

Pending 0?‘ lesion type‘ Also PmYided by Fhe preserft

409,180, ?led Aug 18’ 1932’ now Us. pat NO_

4’483’851.

invention is a method for application of this composi

tion to epidermal burns and wounds, particularly those
10 infected with Pseudomonas, which comprises topically
FIELD OF THE INVENTION

applying the composition to the affected area.

This invention relates to novel compositions and their

DETAILED DESCRIPTION OF THE

use in epidermal burns, and more particulary to novel

INVENTION

compositions useful for the treatment of epidermal mus
cous membranes and muscular burns and wounds or 15

lesions in animals and humans by topical and infusion

AS POhlted Out above, the Present invention is 60n

Cefned With novel compositions and a method for the

application of the composition.

treatment of epidermal burns and wounds, particularly
those infected with Pseudomonas. The composition
BACKGRQUND
inhibits growth of the pseudomonas on the injured area,
There is disclosed in my parent application, Ser. No. 20 and promotes healing in burns and wounds. The compo
409,180, ?led Aug. 18, 1982, now US. Pat. No.
sition of the present invention in its broadest embodi
4,483,85l, the disclosure of which is hereby incorpoment comprises an aqueous solution of dextrose or dex
rated by reference, a composition for topically relating
trose metabolite, a buffering mixture of weak organic
equine metritis comprising the following formulation in
acids and/or alkali metal salts of weak organic acids,
water in a concentration of about 40 to 60 weight per- 25 and a carrier, the solution being characterized as a rela

cent:

tively viscous solution having a pH ranging from about
3.0 to 6.5.
_

lngred‘em
Dextrose
Buffering Mixture
Carrier

_

The most preferred composition may be character

Pans by We‘ght
ZW-NW
49-110
Bil-11¢

ized as containing the following formulation per liter of
30 solution:

Ingredient

These compositions are applied topically to the external genitalia of both male and female horses affected 35
with contagious equine metritis. In several trials the
composition was found to be 100% effective in curing
the diseases if used on two successive days. By compari-

Dextrose
Buffering MiXture
came’

Parts by Weight

sit-50¢
54%
SW15“

This composition also contains about 600 to 1200
son, antibiotics used in the prior art had to be used at
parts of water, and optionally about 5 to 100 parts of an
least ?ve days to be effective, and then were not 100% 40 alkali metal salt of acetic acid. Preferably, the composi
effective.
tion contains citric acid and an alkali metal salt of citric
It has now been discovered that this and related comacid as important buffering components.
positions are broadly effective in treatment of PseudoThe dextrose component of the composition is dex
monas aeruginosa infected burn patients and infected
trose or a dextrose metabolite which is effective to

skin and muscle wounds. When the composition of the 45 provide antibacterial and antifungal properties to the
invention is applied to skin burns or wounds, it provides
composition when used in admixture with the other
dramatic relief of pain, and dramatically accelerates the
components. Thus the dextrose or equivalent material is
healing process.
an important component in the composition.
_
The buffering mixture is also an important ingredient
SUMMARY OF THE INVENTION
50 of the composition. A suf?cient amount of buffer should
It is accordingly one object of the present invention
be present to provide a resulting solution having a pH of
to provide a novel antibacterial composition.
about 3.0 to 6.5, most preferably in the range of 3.2 for
A further object of the invention is to provide novel
antipruritic properties and 6.5 for wounds and burns.
compositions and methods for the treatment of bacterial
Any buffer or mixture of buffers can be used for this

and fungal infections.
55 purpose although mixtures of weak organic acids and
A still further object of the present invention is to
alkali metal salts of organic acids are especially pre
provide a topical composition and methods for its use in
ferred. The amount of buffering agent present is also
the treatment of topical conditions such as burns, blisimportant since the total solution should contain about
ters and infections.
7 to 15 weight percent of buffering agent for a suitable
An even further object of this invention is to provide 60 composition.

a method for treating Pseudomonas infected epidermal
and muscular burns and wounds.

'

Other objects and advantages of the present invention

The preferred buffering agents are polycarboxylic
acids, phosphates, and the like which will provide the

required pH range. The most preferred buffers, how

will become apparent to those skilled in the art as the
ever, comprise a mixture of hydroxy polycarboxylic
description thereof proceeds.
65 acids having about 3 to 8 carbon atoms and their alkali
metal salts, or mixtures thereof. Preferred organic acids
In satisfaction of the foregoing objects and advan
include citric acid, malic acid, tartronic acid, tartaric
tages there is provided by this invention an antibacterial

and antifungal composition for the treatment of epider

acid, and mixtures thereof as well as the sodium and
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potassium salts of these acids. A highly preferred buff
ering system comprises a mixture of citric acid and

4

in curing horses of the contagious equine metritis organ
ism-caused disease.

sodium citrate.

Although the composition was originally developed

The composition optionally contains an alkali metal

for treatment of contagious equine metritis, it has been
found that the composition is also effective against

salt of acetic acid in an amount of about 1 to 4 parts by
weight. The preferred alkali metal salt is sodium ace
tate, although any alkali metal salt of acetic acid may be
used. The salt functions to increase the antifungal activ
ity of the compound. This has also been shown to im

Pseudomonas infections where the infection occurred
on the external genitalia of the affected horses. This
discovery led to the discovery of use of the composition
of the invention for burn patients and patients with skin

part a longer shelf life to the composition. When the

and muscle wounds infected with Pseudomonas bac

terias, particularly Pseudomonas aeruginosa. When the
composition contains the alkali metal salt of acetic acid,
composition was applied to accidental skin burns, it not
the antifungal activity is improved so that it will not
only gave dramatic relief of pain, but also prevented the
support the growth of bacteria or fungi.
blistering of the epidermis as well as dramatically accel
It is also preferred that the resulting solution be a
viscous solution to inhibit drainage from the infected 5 erating wound healing. The same results were obtained
in several cases with skin burns from sun, steam, heat,
organs after topical application. Thus, a carrier vehicle
friction and grease.
is included in the composition to increase the viscosity
The compound was also shown to accelerate the
of the solution. Suitable carriers include polyalkylene
healing of contact (allergenic) dermatitis. When the
glycols, methyl cellulose and the like. The preferred
compound was applied at the time of exposure to poison
carrier vehicle is a lower polyalkylene glycol such as
ivy, the skin lesions of poison ivy did not develop.
glycerine.
When applied to early cases, the compound was shown
The carrier also provides the proper consistency to
to be antipruritic within a few minutes of application,
the composition so that the composition has suf?cient
and greatly accelerated the healing of the skin lesions.
viscosity for topical application. It also provides the
necessary consistency to the solution so it can be used as 25 Similar relief and reduction of swelling was observed in
cases of insect-induced skin reactions. The composition
a lubricant in the treatment of animals such as horses.

is also useful in healing burns caused by friction, chemi

A preferred formulation of the invention comprises
the following components per liter of solution:
Ingredient

cal and heat.

In experiments involving skin and wound lesions of
dogs, cats, cattle and horses, the composition of the
invention was shown to greatly accelerate the healing
of super?cial and deep skin and muscle wounds. It not
only prevented bacterial and fungal infections of the
wound, but it dramatically hastened the healing of the

Parts by Weight

Dextrose
Hydroxy carboxylic acid

591-500
2.5 to IM

Alkali metal salt of

2.5 to M0

hydroxy carboxylic acid
Carrier

SQ-lS?

35 wound and the new growth of skin thereover. In nu

merous cases of animal wounds involving cats, dogs,

cattle and horses, the composition dramatically pro
moted complete wound healing after other “state of the

In a more preferred aspect of the invention, the com
position would also contain an alkali metal salt of acetic

art” medical treatments failed to produce satisfactory
results.
Although the exact mechanism by which the compo
sition works is not known, it was originally developed

acid in an amount of about 5 to 100 parts per liter of

solution. Additionally, the remainder of the solution is
preferably water.
The most preferred composition for use in the present

to enhance the normal bacteria flora of the skin to pro
duce an anti-bacterial-like metabolite to inhibit the

invention comprises the following components:
45

Ingredient

Amount

Dextrose
Citric acid
Sodium citrate
Glycerine

5¢0
1015
50
1%

grams
grams
grams
cc

Sodium acetate
Distilled water

2.5 grams
9% cc

The addition of sodium acetate in the most preferred

embodiment increases the anti—fungal activity of the
compound. The sodium acetate containing compound
was shown to have longer shelf life than the same com

pound without sodium acetate, since it will not support
the growth of bacteria or fungi.
The resulting composition is an aqueous solution with
suf?cient consistency to drain slowly. In use for treat

ment of contagious equine metritis, the composition is
applied topically directly to the external genitalia of
stallions and mares and preferably is used one time each

day for at least two successive days. An effective
amount is simply a thorough application of the viscous
solution to the external genitalia manually. It has been
found that this method will provide 100% effectiveness

growth of the contagious equine metritis (CEM) organ
ism. In addition to the production of the antibacterial

metabolite, it appears that the rapid healing of wounds
caused by the composition of the invention provides an
environment that discourages the growth of pathogenic
bacteria and fungi.
Further, the composition has other bene?cial proper

ties and functions, including anti-pruritic properties,
reduction of tissue ?uids in epidermal vesicles and
wound lesions, increased circulation to wound lesions
and inhibition of bacterial and fungal growth in
wounds.
In preliminary tests on numerous cases of burns and

naturally induced viral, bacterial, fungal, allergic and
traumatic diseases of the eye, external ear, nose, oral

mucosa, periodontal tissues, external genitalia, vagina,
uterus, perianal and dermal tissue, and muscles affected
with deep wound lesions, the composition was shown
to dramatically accelerate the healing of lesions in the
mucous membranes, epidermis, dermis and muscles.
65 With the exception of neoplasia, the compound was
effective on any type of lesion.
The following examples are to illustrate the inven
tion, but the invention is not to be considered as limited

4,600,711
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EXAMPLE 1

The following composition was prepared:
Ingredient

carrier; said composition comprising the following: 50

Parts by Weight

Dextrose
Citric acid

to 500 parts by weight of dextrose, 5 to 200 parts by
weight of buffer comprising a mixture of hydroxy car
boxylic acids and alkali metal salts of hydroxy carbox
ylic acids, 50 to 150 parts by weight of a carrier to
increase viscosity of the composition, and about 5 to 100

250 grams
50 grams

Sodium citrate

25 grams

Glycerine

1% cos.

Water

4WD ccs.

6

increase viscosity of the composition, and about 5 to 100
parts by weight of an alkali metal salt of acetic acid.
2. A composition for the treatment of fungal infec
tions which comprises dextrose in an aqueous based
mixture including a buffer present in suf?cient amounts
to provide a pH in the range of from 3.0 to 6.5, and a

thereto. In the examples and throughout the speci?ca
tion, parts are by weight unless otherwise indicated.

parts be weight of an alkali metal salt of acetic acid.
3. A composition according to claim 2 which com
The resulting composition was a viscous solution 15
prises about 50 to 500 parts of dextrose, about 25 to 100
having a pH of 3.20.
parts of a hydroxy carboxylic acid, about 2.5 to 100
To show the effectiveness of the compound on CEM,
parts of an alkali metal salt of a hydroxy carboxylic
twenty horses were selected for testing. Each of the
acid,
and about 50 to 150 parts of a polyalkylene glycol
twenty horses was treated with a single treatment of the

solution by manually applying topically directly to the

20

external genitalia of the horses. From this test, 17 of the
horses were found to be cured by the single treatment.
The three horses which were not cured with the single

carrier.
4. A composition according to claim 1 wherein the

bacterial infection is a Psuedomonas infection.
5. A composition according to claim 1 or 2 wherein
the components of the composition are contained in a

treatment were then treated again with two successive
treatments which were found to successfully cure the 25 40-60 weight percent concentration in water.
6. A composition according to claim 1 which com
disease. Accordingly, in the ?eld it is recommended
prises about 50 to 500 parts of dextrose, about 25 to 100
that the disease be treated one time per day with appli

parts of a hydroxy carboxylic acid, about 2.5 to 100
parts of an alkali metal salt of a hydroxy carboxylic
acid, and about 50~l50 parts of a carrier.
7. A composition according to claim 6 or 3 wherein

cation of the composition on at least two successive

days.
EXAMPLE 2

the hydroxy polycarboxylic acid component is selected
from the group consisting of citric acid, tartronic acid,
malic acid, tartaric acid, and mixtures thereof.

The following composition is prepared:
Ingredient

Parts by Weight

35

8. A composition according to claim 6 or 3 wherein

Distilled water

9% cc.

the alkali metal salt of the hydroxy polycarboxylic acid

Glycerine
Dextrose
Citric acid
Sodium citrate

1%
59¢
1%
5Q!

is selected from the group consisting of sodium and

Sodium acetate

cc.
grams
grams
grams

potassium salts of citric acid, tartronic acid, malic acid,
tartaric acid, and mixtures thereof.
9. A composition according to claim 6 or 3 wherein
the carrier is a polyalkylene glycol.
10. A composition according to claim 1 or 2 which
comprises 250 parts dextrose, 50 parts citric acid, 25

2.5 grams

The resulting composition is a viscous solution hav

ing a pH of 3.0. The compound of the invention is topi

cally applied to ten patients having second degree epi
dermal heat burns. In all ten cases, the patients experi
ence dramatic relief of pain, and no blistering of the
burn area occurs. Further, the healing time of the burn
is dramatically accelerated. In addition, none of the

patients develop Pseudomonas aeruginosa infections in

parts sodium citrate, 100 ccs. glycerine and 400 ccs.
45 water, said composition being in the form of a viscous

solution having a pH in the range of 3.2.
11. A composition according to claim 1 or 2 compris

ing:
50

the area of the burn. Similar results are obtained in cases
where the skin burns are caused from sun, steam, fric

tion and grease.
The invention has been described herein with refer
ence to certain preferred embodiments. However, as 55
obvious variations thereon will become apparent to
those skilled in the art, the invention is not to be consid»

Ingredient

Parts by Weight

Dextrose
Citric acid
Sodium citrate
Glycerine

5%
libtb
593
1%

grams
grams
grams
cc

Sodium acetate
Distilled water

2.5 grams
90¢ cc

ered as limited thereto.

12. A method for the treatment of epidermal and

I claim:
1. A composition for the treatment of bacterial infec
tions which comprises dextrose in an aqueous based
mixture including a buffer present in suf?cient amounts
to provide a pH in the range of from 3.0 to 6.5, and a

an effective amount to the burn area of an aqueous

carrier; said composition comprising the following: 50

and a carrier.

muscular burns which comprises topical application of
based mixture of dextrose, a buffer present in sufficient
amounts to provide a pH in the range of about 3.0 to 4.5

13. A method for the treatment of epidermal and
to 500 parts by weight of dextrose, 5 to 200 parts by 65
muscular wounds which comprises topical application
weight of buffer comprising a mixture of hydroxy car
of an effective amount to the wound area of an aqueous
boxylic acids and alkali metal salts of hydroxy carbox
based mixture of dextrose, a buffer present in sufficient
ylic acids, 50 to 150 parts by weight of a carrier to

4,600,711
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amounts to provide a pH in the range of about 3.0 to 4.5

8

from the group consisting of citric acid, tartronic acid,
malic acid, tartaric acid, and mixtures thereof.

and a carrier.

14. A method according to claim 12 or 13 where the
17. A method according to claim 12 or 13 wherein the
components of the composition are contained in a 40-60
alkali metal salt of the hydroxy polycarboxylic acid is
weight percent concentration in water and are present 5

selected from the group consisting of sodium and potas
sium salts of citric acid, tartronic acid, malic acid, tar
taric acid, and mixtures thereof.
18. A method according to claim 12 or 13 wherein the
carrier is a polyalkylene glycol.

in the following amounts by weight:
Ingredient

Parts by Weight

Dextrose
Buffer
Carrier

56-500 grams
5-2Q? grams
50-5¢¢ grams

19, A method according to claim 12 or 13 wherein the

composition additionally comprises an alkali metal salt
of acetic acid.

15. A method according to claim 12 or 13 wherein the

20. A method according to claim 12 or 13 wherein the
burn or wound site is infected with Pseudomonas.
21. A method for the treatment of contact dermatitis

composition comprises about 50-500 parts of dextrose,
about 25-100 parts of hydroxy carboxylic acid, about
25-100 parts of an alkali metal salt of a hydroxy carbox
ylic acid, and about 50-150 parts of a carrier.
16. A method according to claim 12 or 13 wherein the

which comprises applying the composition of claim 1 or
2 topically to the site of the contact dermatitis.

hydroxy polycarboxylic acid component is selected

5%

25

30

35

40

45

55

65

*

*

*

*

